DXCM's Preliminary Results Show Strong Growth: How to Play the Stock?

DexCom Inc. (DXCM) is off to a strong start in 2025, with its stock rallying 5.7% following the release of its preliminary results for the fourth quarter and fiscal 2024 on Jan. 13, 2025. The company’s robust performance has reaffirmed investor confidence, driven by impressive revenue growth and a promising outlook for 2025. The upbeat results demonstrate DexCom’s position as a key player in the continuous glucose monitoring (CGM) market.The preliminary report highlighted fourth-quarter fiscal 2024 total re ...